Oldest pages
Showing below up to 50 results in range #71 to #120.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- ARRIVE 2.0 (09:36, 29 September 2020)
- 3.4.1 Animal characteristics, care and use (10:15, 29 September 2020)
- 3.4.1.1 Ethical evaluation and authorization process of animal use (09:22, 1 October 2020)
- PREPARE (14:42, 2 October 2020)
- 4.2.3 Responsible conduct of research (15:36, 3 November 2020)
- 3.1.3 Data security (08:18, 9 November 2020)
- 3.4.2.2 Antibody validation (12:07, 24 November 2020)
- 3.2.4 Training on specific methods, tasks and activities (10:45, 8 December 2020)
- 3.4.2.3 Biological and technical replicates (16:48, 3 February 2021)
- 3.1.2 Procedures for how and when to record data (09:01, 12 February 2021)
- 1.3.1 Transparency (10:21, 15 February 2021)
- 1.5.1 Quality policy (10:23, 15 February 2021)
- 1.5.2.3 Process owner (10:24, 15 February 2021)
- 1.5.4 Prevention of Conflict of Interest (10:25, 15 February 2021)
- 3.1.2.2 Process for witnessing of records (10:29, 15 February 2021)
- 4.3.1.2 Deleting items (09:53, 22 February 2021)
- 2.1.8 Randomisation (07:34, 4 March 2021)
- 2.3.1.1 Converting non-electronic information into an electronic form (09:31, 10 March 2021)
- EQIPD principles (09:14, 16 March 2021)
- Performance Standards (09:18, 18 March 2021)
- FAQ (19:40, 23 March 2021)
- 2.3.4 Data visualization (19:41, 23 March 2021)
- 2.3.3 Statistical analysis (19:41, 23 March 2021)
- 2.1.10 Plausibility check (19:43, 23 March 2021)
- 2.1.7 Blinding (19:43, 23 March 2021)
- 1.5.2.7 Quality professionals (19:46, 23 March 2021)
- 1.5.2.5 Research team (19:47, 23 March 2021)
- 2.1.3 Appraisal of literature and systematic reviews (12:43, 24 March 2021)
- 2.1.9 Inclusion and exclusion criteria (12:46, 24 March 2021)
- 2.4 Reporting (12:47, 24 March 2021)
- 1.5.2.4 Principal investigators and study directors (12:54, 24 March 2021)
- ARRIVE Essential - Outcome measures (13:02, 24 March 2021)
- 2.1.5 Pre-specification (13:03, 24 March 2021)
- 1.4.3 Quality in collaborative research (06:38, 25 March 2021)
- 4.3.2 Using the EQIPD applications (16:51, 29 March 2021)
- 4.3.2.2 Creating NEEDs (16:53, 29 March 2021)
- 4.3.2.3 Revising NEEDs (12:47, 31 March 2021)
- 1.1 Mission (16:04, 7 April 2021)
- 1.5.2 Roles and responsibilities of involved personnel and organization (09:23, 9 April 2021)
- EQIPD for Core Facilities (12:39, 15 April 2021)
- 2.3.2 Primary analysis and evaluation of raw data (13:17, 15 April 2021)
- 2.2.3 Documentation of the experiment and deviations (13:27, 15 April 2021)
- 1.2 Scope (06:44, 20 April 2021)
- 2.1.2 Unique study ID (07:51, 28 April 2021)
- Examples of implementing a unique study ID (07:51, 29 April 2021)
- Documentation in EQIPD (08:49, 6 May 2021)
- 1.4.2 Adherence to legal and regulatory considerations (06:45, 7 May 2021)
- Core Requirements (17:55, 10 May 2021)
- Experimental Record (18:22, 10 May 2021)
- 4.3.2.1 Using the Planning Tool (07:50, 14 May 2021)